X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2023/05/30/2678304/0/en/Captor-Therapeutics-Publishes-Q1-2023-Financial-Results.html
https://www.globenewswire.com/news-release/2023/03/28/2635336/0/en/Captor-Therapeutics-Discloses-Molecular-Targets-of-Pipeline-s-Lead-Assets-and-Invites-Stakeholders-to-Webcast.html
https://www.globenewswire.com/news-release/2023/03/07/2621687/0/en/Captor-Therapeutics-Announces-Three-Year-Strategic-Objectives.html
https://www.globenewswire.com/news-release/2022/11/25/2562604/0/en/Captor-Therapeutics-Reports-Q3-2022-Results-and-Provides-Business-Update.html
https://www.globenewswire.com/news-release/2022/11/14/2554821/0/en/Ono-Pharmaceutical-and-Captor-Therapeutics-Announce-Drug-Discovery-Collaboration-to-Develop-Small-Molecule-Protein-Degraders-for-the-Treatment-of-Neurodegenerative-Diseases.html
https://www.captortherapeutics.com/news/65/captor-therapeutics-announces-participation-in-upcoming-scientific-investor-and-partnering-conferences-in-october-2022
https://www.captortherapeutics.com/news/64/captor-therapeutics-first-half-of-2022-marked-by-significant-progress-in-rd-and-preparations-for-the-commencement-of-clinical-trials
https://www.contractpharma.com/contents/view_breaking-news/2022-08-10/captor-therapeutics-selects-cdmo-for-clinical-trial-materials/?widget=listSection
https://www.globenewswire.com/news-release/2022/08/10/2495459/0/en/Captor-Therapeutics-Nominates-the-Molecular-Glue-CPT-6281-as-Drug-Candidate-to-Enter-CTA-IND-Enabling-Studies-for-the-Treatment-of-Hepatocellular-Carcinoma.html
Market Place
Share 
